(19)
(11) EP 1 592 808 A2

(12)

(88) Date of publication A3:
21.10.2004

(43) Date of publication:
09.11.2005 Bulletin 2005/45

(21) Application number: 04704556.2

(22) Date of filing: 23.01.2004
(51) International Patent Classification (IPC)7: C12Q 1/68, G01N 33/50, C07K 14/47, C12N 15/63, A61K 48/00, A61K 38/17
(86) International application number:
PCT/EP2004/000539
(87) International publication number:
WO 2004/067774 (12.08.2004 Gazette 2004/33)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 31.01.2003 EP 03002212
03.02.2003 EP 03002153

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • STROPP, Udo
    42781 Haan (DE)
  • SCHWERS, Stephan
    51145 Köln (DE)
  • KALLABIS, Harald
    51061 Köln (DE)

   


(54) SINGLE NUCLEOTIDE POLYMORPHISMS AS PREDICTIVE DIAGNOSTICS FOR ADVERSE DRUG REACTIONS (ADR) AND DRUG EFFICACY